Article
Single-cell foundation models predict durable CAR T response despite imperfect cell annotation
2026-07-31
Abstract excerpt
<title>Abstract</title> <p>CD19-targeted chimeric antigen receptor (CAR) T cell therapy achieves high initial response rates in B-cell acute lymphoblastic leukemia (B-ALL), yet half of patients relapse within one year. Pre-infusion product composition decoded by single-cell RNA sequencing (scRNA-seq) carries information predictive of long-term CAR T persistence, but extracting this information from individual pat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 198d2bb3-8071-51de-ae9c-b5d89087c4d5
- DOI
- 10.21203/rs.3.rs-10412263/v1
